Companion Diagnostic Development

We Build. We Validate. We Deliver.

ResearchDx integrates and aligns IVD and biopharma development that simplifies, speeds and ensures delivery of your FDA-approved companion diagnostics on time.

We Are With You Every Step of the Way.

Identify & Finalize Biomarker(s)

Develop & Refine IVD Assay

Validate in Clinical Trials

FDA Regulatory Filing / Approval

GMP Manufacture Final IVD Kit

CompanionDX to Market

We Are With You Every Step of the Way.

Identify & Finalize Biomarker(s)

Develop & Refine IVD Assay

Validate in Clinical Trials

FDA Regulatory Filing / Approval

GMP Manufacture Final IVD Kit

CompanionDX to Market

No Multi-Partner Outsourcing.

Watch CDO Video

BioPharma Services

Diagnostic resources and expertise to support all phases of FDA drug and companion diagnostic development.

IVD Diagnostics

One-stop shop for IVD diagnostics outsourcing for biopharma, biotechnology, diagnostics companies, clinical laboratories, medical research and physicians.

Clinical Trial Consulting

Full clinical trials program services to support an FDA IVD product filing.

Latest News

Molecular Medicine Tri-Con Meeting

Irvine, CA — Jan 28, 2020 — ResearchDx will attend the Molecular Medicine Tri-Con Meeting in San Francisco California, March 1–4. Please visit our booth #600, or call us at 866.225.9195 or 949.812.6901 to set up a consultation at the show.

Negative Gluten ID Test Results can ‘Rule Out’ Celiac Disease in High Risk Populations

Brief: First degree relatives of individuals with celiac disease are at elevated risk for developing a similarly severe gluten intolerance disorder. However, a quick screening test for the genetic alterations responsible for encoding gluten recognition immune receptors can rule out celiac disease risk in these individuals. Developed by Targeted Genomics, the DNA-based, non-invasive Gluten ID […]